A Liver Nodule Exhibiting Arterial Enhancement and Washout in a Patient with Alcohol-Related and Metabolic Liver Disease
By
Soon Kyu Lee
Sun Young Jun
Young Chul Yoon
July 1, 2026
Clinical Scorecard: A Liver Nodule Exhibiting Arterial Enhancement and Washout in a Patient with Alcohol-Related and Metabolic Liver Disease
At a Glance
Category Detail
Condition Primary Hepatic Gastrointestinal Stromal Tumor (GIST) Key Mechanisms Arterial phase hyperenhancement and washout on MRI, associated with advanced liver disease. Target Population Patients with metabolic dysfunction and alcohol-related liver disease. Care Setting Hepatology center
Key Highlights
Patient presented with a 5.3-cm hepatic nodule and advanced hepatic fibrosis. MRI findings fulfilled LI-RADS 5 criteria, suggesting hypervascular tumor. Histopathological analysis confirmed diagnosis of primary hepatic GIST. Standard treatment involved surgical resection followed by adjuvant imatinib therapy. Primary hepatic GISTs are rare, with only approximately 40 cases reported. Guideline-Based Recommendations
Diagnosis
Differential diagnosis should include hypervascular tumors and GIST based on imaging findings. Management
Surgical resection is the standard treatment for localized GIST. Monitoring & Follow-up
Adjuvant imatinib therapy is recommended for high-risk cases. Risks
Consideration of rare hepatic tumors in patients with chronic liver disease and typical HCC imaging features. Patient & Prescribing Data
Patients with hepatic GIST and chronic liver disease.
Imatinib therapy (400 mg once daily) is indicated for high-risk cases post-surgery.
Clinical Best Practices
Utilize dynamic contrast-enhanced MRI for characterization of hepatic lesions. Consider advanced liver disease when interpreting imaging findings. Related Resources & Content
